Literature DB >> 12168094

Bcl-xL overexpression in human hepatocellular carcinoma.

Jota Watanabe1, Fumiki Kushihata, Kazuo Honda, Katsumi Mominoki, Seiji Matsuda, Nobuaki Kobayashi.   

Abstract

It is known that proliferation and apoptosis are closely related phenomena in liver cancer cells. In this study, using surgical specimens from 42 patients with hepatocellular carcinoma (HCC), we investigated the expression and localization of Bcl-xL, an antiapoptosis-related protein of the Bcl-2 family. Using Western blotting, Bcl-xL expression was detected in both cancerous and non-cancerous specimens from all of the HCC patients, and elevated Bcl-xL levels were found in cancerous specimens from two thirds of the patients. In normal human liver specimens, Bcl-xL was found mainly in the cytoplasm of hepatocytes, although it was also found in the cytoplasm of bile duct cells in Glisson's capsule by immunohistochemical staining. To the best of our knowledge, this is the first report of Bcl-xL overexpression and localization in HCC specimens. Bcl-xL was found not only in the cytoplasm of HCC cells, but also in the nuclei of some HCC cells, suggesting that Bcl-xL is involved in the progression of HCC cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12168094

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  17 in total

1.  TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.

Authors:  Bruno-Christian Koehler; Toni Urbanik; Binje Vick; Regina-Johanna Boger; Steffen Heeger; Peter-R Galle; Marcus Schuchmann; Henning Schulze-Bergkamen
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

2.  Effect of short hairpin RNA of Bcl-xL gene on biological behaviors of HepG-2 cells.

Authors:  Duan Mengxi; Yuan Hong; Wang Nan; Li Shijun; Jiang Yanmei
Journal:  Med Oncol       Date:  2011-04-29       Impact factor: 3.064

3.  Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins.

Authors:  Jiajie George Lu; Luan Nguyen; Sara Samadzadeh; Maryam Masouminia; Alejandro Mendoza; Owen Sweeney; Brittany Tillman; Nikoo Afifyan; Timothy Morgan; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2018-02-06       Impact factor: 3.362

Review 4.  Apoptotic cell signaling in cancer progression and therapy.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  Integr Biol (Camb)       Date:  2011-02-22       Impact factor: 2.192

5.  Serine threonine kinase Pim-3 regulates STAT3 pathway to inhibit proliferation of human liver cancers.

Authors:  Jianqiang Wang; Lijun Lao; Hui Zhao; Yuan Huang
Journal:  Int J Clin Exp Med       Date:  2014-02-15

6.  Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells.

Authors:  Sylvia S Gayle; Jennifer M Sahni; Bryan M Webb; Kristen L Weber-Bonk; Melyssa S Shively; Raffaella Spina; Eli E Bar; Mathew K Summers; Ruth A Keri
Journal:  J Biol Chem       Date:  2018-11-27       Impact factor: 5.157

7.  Targeting of the Akt-nuclear factor-kappa B signaling network by [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of hepatocellular carcinoma.

Authors:  Hany A Omar; Aaron M Sargeant; Jing-Ru Weng; Dasheng Wang; Samuel K Kulp; Tushar Patel; Ching-Shih Chen
Journal:  Mol Pharmacol       Date:  2009-08-25       Impact factor: 4.436

8.  Prokaryotic expression, purification and functional characterization of recombinant human RIP2.

Authors:  Xin Cai; Min Wang; Haibo Kong; Jing Liu; Ye Liu; Wengrong Xia; Minji Zou; Jiaxi Wang; Hang Su; Donggang Xu
Journal:  Mol Biol Rep       Date:  2012-11-08       Impact factor: 2.316

Review 9.  Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies.

Authors:  Alex R D Delbridge; Stephanie Grabow; Andreas Strasser; David L Vaux
Journal:  Nat Rev Cancer       Date:  2016-02       Impact factor: 60.716

10.  Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform.

Authors:  Timothée Revil; Jordan Pelletier; Johanne Toutant; Alexandre Cloutier; Benoit Chabot
Journal:  J Biol Chem       Date:  2009-06-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.